“Is prostate cancer screening right for you?”

The following infographic was also issued today by the U.S. Preventive Services Task Force (USPSTF) and offers guidance as to the appropriateness of prostate cancer screening for an average, 55- to 69-year-old American male with no specific, known risk factors for prostate cancer: … READ MORE …

USPSTF releases new guidance about prostate cancer screening

Earlier today, the US Preventive Services Task Force (USPSTF) issued the final version of its revised guidance on screening for risk of prostate cancer. … READ MORE …

A problem with cancer screening (at least in the USA)

According to a recent report in the American Journal of Preventive Medicine, only 5.6 percent of a sample of 3,677 Americans of 18 years of age or older could correctly evaluate four simple statements about cancer screening. … READ MORE …

The 400,000+ CAP screening trial reports initial results

A while ago now we had first mentioned the “Cluster randomized trial of PSA testing for prostate cancer” or CAP trial — the single largest randomized trial of PSA screening for risk of prostate cancer to be implemented. … READ MORE …

Understanding genetics, genomics, and their utility in prostate cancer

Our friends at UroToday have just published a perfectly lovely lecture on this topic given by Prof. Lenny Gomella at the recent annual meeting of the Large Urology Group Practice Association (LUGPA). … READ MORE …

Reports from the EAU “Update on Prostate Cancer” meeting in Vienna

The European Association of Urology (EAU) “Update on Prostate Cancer” meeting was held in Vienna, Austria, on Friday and Saturday, and Dr. Zachary Klaassen was again busy providing summary reports on presentations for UroToday. … READ MORE …

The prostate cancer “screening” controversy … an update

Yesterday we mentioned a new paper on PSA screening by Tsodikov et al. in the Annals of Internal Medicine. We have now had the chance to read the full text of that paper, as well as the associated editorial by Vickers in the same issue of the journal. … READ MORE …